Global Injectable PrEP Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Injectable PrEP market size was valued at US$ 317 million in 2025 and is forecast to a readjusted size of US$ 833 million by 2032 with a CAGR of 14.8% during review period.
Injectable PrEP refers to HIV pre-exposure prophylaxis administered via parenteral routes—typically intramuscular or subcutaneous injection—most often in long-acting formulations that create a sustained-release “depot” and maintain protective drug exposure for weeks to months before potential HIV exposure occurs. The core problem it is designed to solve is the real-world implementation gap of oral PrEP: daily or event-driven pill-taking can be difficult to sustain due to adherence burden, refill continuity, privacy constraints, and stigma associated with visible medication use, and missed doses or interruptions can translate into gaps in protection. By shifting prevention from frequent self-managed dosing to periodic clinic- or program-based administration, injectable PrEP aims to improve continuity of coverage, reduce day-to-day behavioral load, and integrate more naturally with testing, follow-up, and broader sexual health services. Historically, injectable PrEP emerged after oral PrEP established efficacy and guidelines, leveraging advances from long-acting HIV treatment technologies—such as micro-/nano-crystal suspensions, stable depot formulations, and aseptic fill-finish—before expanding through regulatory approvals and phased rollout across regions, with service delivery models (visit cadence, workforce training, cold chain, and retention-in-care) becoming a central determinant of real-world uptake. Upstream, injectable PrEP depends on both conventional pharmaceutical inputs and a component-intensive aseptic supply chain: APIs and key intermediates; chemical reagents, solvents, and catalysts; injection-grade excipients (stabilizers, surfactants, buffers, water for injection, and formulation aids as needed); and the packaging/device components required for sterile manufacturing and administration (injectable-grade glass vials or prefilled syringes, elastomer stoppers/plungers, seals, needles and safety injection devices, sterilizing filters, single-use tubing and filling sets, labels, and cold-chain packaging), supported by specialized suppliers providing aseptic fill-finish capacity, sterilization validation, temperature-controlled logistics, and compliant quality systems.In 2025, the global production capacity of injectable PrEP reached 150,000 doses, while total sales amounted to 115,700 doses. The average selling price was USD 2,660 per dose, and manufacturers’ gross margins ranged between 60% and 70%.
This report is a detailed and comprehensive analysis for global Injectable PrEP market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Injectable PrEP market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Injectable PrEP market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Injectable PrEP market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Injectable PrEP market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Injectable PrEP
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Injectable PrEP market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Gilead Sciences, ViiV Healthcare, Aurobindo, Cipla, Viatris, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Injectable PrEP market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Injectable PrEP product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Injectable PrEP, with price, sales quantity, revenue, and global market share of Injectable PrEP from 2021 to 2026.
Chapter 3, the Injectable PrEP competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Injectable PrEP breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Injectable PrEP market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Injectable PrEP.
Chapter 14 and 15, to describe Injectable PrEP sales channel, distributors, customers, research findings and conclusion.
Injectable PrEP refers to HIV pre-exposure prophylaxis administered via parenteral routes—typically intramuscular or subcutaneous injection—most often in long-acting formulations that create a sustained-release “depot” and maintain protective drug exposure for weeks to months before potential HIV exposure occurs. The core problem it is designed to solve is the real-world implementation gap of oral PrEP: daily or event-driven pill-taking can be difficult to sustain due to adherence burden, refill continuity, privacy constraints, and stigma associated with visible medication use, and missed doses or interruptions can translate into gaps in protection. By shifting prevention from frequent self-managed dosing to periodic clinic- or program-based administration, injectable PrEP aims to improve continuity of coverage, reduce day-to-day behavioral load, and integrate more naturally with testing, follow-up, and broader sexual health services. Historically, injectable PrEP emerged after oral PrEP established efficacy and guidelines, leveraging advances from long-acting HIV treatment technologies—such as micro-/nano-crystal suspensions, stable depot formulations, and aseptic fill-finish—before expanding through regulatory approvals and phased rollout across regions, with service delivery models (visit cadence, workforce training, cold chain, and retention-in-care) becoming a central determinant of real-world uptake. Upstream, injectable PrEP depends on both conventional pharmaceutical inputs and a component-intensive aseptic supply chain: APIs and key intermediates; chemical reagents, solvents, and catalysts; injection-grade excipients (stabilizers, surfactants, buffers, water for injection, and formulation aids as needed); and the packaging/device components required for sterile manufacturing and administration (injectable-grade glass vials or prefilled syringes, elastomer stoppers/plungers, seals, needles and safety injection devices, sterilizing filters, single-use tubing and filling sets, labels, and cold-chain packaging), supported by specialized suppliers providing aseptic fill-finish capacity, sterilization validation, temperature-controlled logistics, and compliant quality systems.In 2025, the global production capacity of injectable PrEP reached 150,000 doses, while total sales amounted to 115,700 doses. The average selling price was USD 2,660 per dose, and manufacturers’ gross margins ranged between 60% and 70%.
This report is a detailed and comprehensive analysis for global Injectable PrEP market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Injectable PrEP market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Injectable PrEP market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Injectable PrEP market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Injectable PrEP market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Injectable PrEP
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Injectable PrEP market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Gilead Sciences, ViiV Healthcare, Aurobindo, Cipla, Viatris, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Injectable PrEP market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Cabotegravir
- Lenacapavir
- Other
- Short-interval Injections
- Monthly Injections
- Quarterly Injections
- Original Drug
- Generic Drug
- Hospital
- Clinic
- Other
- Gilead Sciences
- ViiV Healthcare
- Aurobindo
- Cipla
- Viatris
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Injectable PrEP product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Injectable PrEP, with price, sales quantity, revenue, and global market share of Injectable PrEP from 2021 to 2026.
Chapter 3, the Injectable PrEP competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Injectable PrEP breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Injectable PrEP market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Injectable PrEP.
Chapter 14 and 15, to describe Injectable PrEP sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Injectable PrEP Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Cabotegravir
1.3.3 Lenacapavir
1.3.4 Other
1.4 Market Analysis by Dosing Interval
1.4.1 Overview: Global Injectable PrEP Consumption Value by Dosing Interval: 2021 Versus 2025 Versus 2032
1.4.2 Short-interval Injections
1.4.3 Monthly Injections
1.4.4 Quarterly Injections
1.5 Market Analysis by Drug Properties
1.5.1 Overview: Global Injectable PrEP Consumption Value by Drug Properties: 2021 Versus 2025 Versus 2032
1.5.2 Original Drug
1.5.3 Generic Drug
1.6 Market Analysis by Application
1.6.1 Overview: Global Injectable PrEP Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Hospital
1.6.3 Clinic
1.6.4 Other
1.7 Global Injectable PrEP Market Size & Forecast
1.7.1 Global Injectable PrEP Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Injectable PrEP Sales Quantity (2021-2032)
1.7.3 Global Injectable PrEP Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Gilead Sciences
2.1.1 Gilead Sciences Details
2.1.2 Gilead Sciences Major Business
2.1.3 Gilead Sciences Injectable PrEP Product and Services
2.1.4 Gilead Sciences Injectable PrEP Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Gilead Sciences Recent Developments/Updates
2.2 ViiV Healthcare
2.2.1 ViiV Healthcare Details
2.2.2 ViiV Healthcare Major Business
2.2.3 ViiV Healthcare Injectable PrEP Product and Services
2.2.4 ViiV Healthcare Injectable PrEP Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 ViiV Healthcare Recent Developments/Updates
2.3 Aurobindo
2.3.1 Aurobindo Details
2.3.2 Aurobindo Major Business
2.3.3 Aurobindo Injectable PrEP Product and Services
2.3.4 Aurobindo Injectable PrEP Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Aurobindo Recent Developments/Updates
2.4 Cipla
2.4.1 Cipla Details
2.4.2 Cipla Major Business
2.4.3 Cipla Injectable PrEP Product and Services
2.4.4 Cipla Injectable PrEP Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Cipla Recent Developments/Updates
2.5 Viatris
2.5.1 Viatris Details
2.5.2 Viatris Major Business
2.5.3 Viatris Injectable PrEP Product and Services
2.5.4 Viatris Injectable PrEP Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Viatris Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: INJECTABLE PREP BY MANUFACTURER
3.1 Global Injectable PrEP Sales Quantity by Manufacturer (2021-2026)
3.2 Global Injectable PrEP Revenue by Manufacturer (2021-2026)
3.3 Global Injectable PrEP Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Injectable PrEP by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Injectable PrEP Manufacturer Market Share in 2025
3.4.3 Top 6 Injectable PrEP Manufacturer Market Share in 2025
3.5 Injectable PrEP Market: Overall Company Footprint Analysis
3.5.1 Injectable PrEP Market: Region Footprint
3.5.2 Injectable PrEP Market: Company Product Type Footprint
3.5.3 Injectable PrEP Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Injectable PrEP Market Size by Region
4.1.1 Global Injectable PrEP Sales Quantity by Region (2021-2032)
4.1.2 Global Injectable PrEP Consumption Value by Region (2021-2032)
4.1.3 Global Injectable PrEP Average Price by Region (2021-2032)
4.2 North America Injectable PrEP Consumption Value (2021-2032)
4.3 Europe Injectable PrEP Consumption Value (2021-2032)
4.4 Asia-Pacific Injectable PrEP Consumption Value (2021-2032)
4.5 South America Injectable PrEP Consumption Value (2021-2032)
4.6 Middle East & Africa Injectable PrEP Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Injectable PrEP Sales Quantity by Type (2021-2032)
5.2 Global Injectable PrEP Consumption Value by Type (2021-2032)
5.3 Global Injectable PrEP Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Injectable PrEP Sales Quantity by Application (2021-2032)
6.2 Global Injectable PrEP Consumption Value by Application (2021-2032)
6.3 Global Injectable PrEP Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Injectable PrEP Sales Quantity by Type (2021-2032)
7.2 North America Injectable PrEP Sales Quantity by Application (2021-2032)
7.3 North America Injectable PrEP Market Size by Country
7.3.1 North America Injectable PrEP Sales Quantity by Country (2021-2032)
7.3.2 North America Injectable PrEP Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Injectable PrEP Sales Quantity by Type (2021-2032)
8.2 Europe Injectable PrEP Sales Quantity by Application (2021-2032)
8.3 Europe Injectable PrEP Market Size by Country
8.3.1 Europe Injectable PrEP Sales Quantity by Country (2021-2032)
8.3.2 Europe Injectable PrEP Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Injectable PrEP Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Injectable PrEP Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Injectable PrEP Market Size by Region
9.3.1 Asia-Pacific Injectable PrEP Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Injectable PrEP Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Injectable PrEP Sales Quantity by Type (2021-2032)
10.2 South America Injectable PrEP Sales Quantity by Application (2021-2032)
10.3 South America Injectable PrEP Market Size by Country
10.3.1 South America Injectable PrEP Sales Quantity by Country (2021-2032)
10.3.2 South America Injectable PrEP Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Injectable PrEP Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Injectable PrEP Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Injectable PrEP Market Size by Country
11.3.1 Middle East & Africa Injectable PrEP Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Injectable PrEP Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Injectable PrEP Market Drivers
12.2 Injectable PrEP Market Restraints
12.3 Injectable PrEP Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Injectable PrEP and Key Manufacturers
13.2 Manufacturing Costs Percentage of Injectable PrEP
13.3 Injectable PrEP Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Injectable PrEP Typical Distributors
14.3 Injectable PrEP Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Injectable PrEP Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Cabotegravir
1.3.3 Lenacapavir
1.3.4 Other
1.4 Market Analysis by Dosing Interval
1.4.1 Overview: Global Injectable PrEP Consumption Value by Dosing Interval: 2021 Versus 2025 Versus 2032
1.4.2 Short-interval Injections
1.4.3 Monthly Injections
1.4.4 Quarterly Injections
1.5 Market Analysis by Drug Properties
1.5.1 Overview: Global Injectable PrEP Consumption Value by Drug Properties: 2021 Versus 2025 Versus 2032
1.5.2 Original Drug
1.5.3 Generic Drug
1.6 Market Analysis by Application
1.6.1 Overview: Global Injectable PrEP Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Hospital
1.6.3 Clinic
1.6.4 Other
1.7 Global Injectable PrEP Market Size & Forecast
1.7.1 Global Injectable PrEP Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Injectable PrEP Sales Quantity (2021-2032)
1.7.3 Global Injectable PrEP Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Gilead Sciences
2.1.1 Gilead Sciences Details
2.1.2 Gilead Sciences Major Business
2.1.3 Gilead Sciences Injectable PrEP Product and Services
2.1.4 Gilead Sciences Injectable PrEP Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Gilead Sciences Recent Developments/Updates
2.2 ViiV Healthcare
2.2.1 ViiV Healthcare Details
2.2.2 ViiV Healthcare Major Business
2.2.3 ViiV Healthcare Injectable PrEP Product and Services
2.2.4 ViiV Healthcare Injectable PrEP Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 ViiV Healthcare Recent Developments/Updates
2.3 Aurobindo
2.3.1 Aurobindo Details
2.3.2 Aurobindo Major Business
2.3.3 Aurobindo Injectable PrEP Product and Services
2.3.4 Aurobindo Injectable PrEP Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Aurobindo Recent Developments/Updates
2.4 Cipla
2.4.1 Cipla Details
2.4.2 Cipla Major Business
2.4.3 Cipla Injectable PrEP Product and Services
2.4.4 Cipla Injectable PrEP Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Cipla Recent Developments/Updates
2.5 Viatris
2.5.1 Viatris Details
2.5.2 Viatris Major Business
2.5.3 Viatris Injectable PrEP Product and Services
2.5.4 Viatris Injectable PrEP Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Viatris Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: INJECTABLE PREP BY MANUFACTURER
3.1 Global Injectable PrEP Sales Quantity by Manufacturer (2021-2026)
3.2 Global Injectable PrEP Revenue by Manufacturer (2021-2026)
3.3 Global Injectable PrEP Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Injectable PrEP by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Injectable PrEP Manufacturer Market Share in 2025
3.4.3 Top 6 Injectable PrEP Manufacturer Market Share in 2025
3.5 Injectable PrEP Market: Overall Company Footprint Analysis
3.5.1 Injectable PrEP Market: Region Footprint
3.5.2 Injectable PrEP Market: Company Product Type Footprint
3.5.3 Injectable PrEP Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Injectable PrEP Market Size by Region
4.1.1 Global Injectable PrEP Sales Quantity by Region (2021-2032)
4.1.2 Global Injectable PrEP Consumption Value by Region (2021-2032)
4.1.3 Global Injectable PrEP Average Price by Region (2021-2032)
4.2 North America Injectable PrEP Consumption Value (2021-2032)
4.3 Europe Injectable PrEP Consumption Value (2021-2032)
4.4 Asia-Pacific Injectable PrEP Consumption Value (2021-2032)
4.5 South America Injectable PrEP Consumption Value (2021-2032)
4.6 Middle East & Africa Injectable PrEP Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Injectable PrEP Sales Quantity by Type (2021-2032)
5.2 Global Injectable PrEP Consumption Value by Type (2021-2032)
5.3 Global Injectable PrEP Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Injectable PrEP Sales Quantity by Application (2021-2032)
6.2 Global Injectable PrEP Consumption Value by Application (2021-2032)
6.3 Global Injectable PrEP Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Injectable PrEP Sales Quantity by Type (2021-2032)
7.2 North America Injectable PrEP Sales Quantity by Application (2021-2032)
7.3 North America Injectable PrEP Market Size by Country
7.3.1 North America Injectable PrEP Sales Quantity by Country (2021-2032)
7.3.2 North America Injectable PrEP Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Injectable PrEP Sales Quantity by Type (2021-2032)
8.2 Europe Injectable PrEP Sales Quantity by Application (2021-2032)
8.3 Europe Injectable PrEP Market Size by Country
8.3.1 Europe Injectable PrEP Sales Quantity by Country (2021-2032)
8.3.2 Europe Injectable PrEP Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Injectable PrEP Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Injectable PrEP Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Injectable PrEP Market Size by Region
9.3.1 Asia-Pacific Injectable PrEP Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Injectable PrEP Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Injectable PrEP Sales Quantity by Type (2021-2032)
10.2 South America Injectable PrEP Sales Quantity by Application (2021-2032)
10.3 South America Injectable PrEP Market Size by Country
10.3.1 South America Injectable PrEP Sales Quantity by Country (2021-2032)
10.3.2 South America Injectable PrEP Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Injectable PrEP Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Injectable PrEP Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Injectable PrEP Market Size by Country
11.3.1 Middle East & Africa Injectable PrEP Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Injectable PrEP Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Injectable PrEP Market Drivers
12.2 Injectable PrEP Market Restraints
12.3 Injectable PrEP Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Injectable PrEP and Key Manufacturers
13.2 Manufacturing Costs Percentage of Injectable PrEP
13.3 Injectable PrEP Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Injectable PrEP Typical Distributors
14.3 Injectable PrEP Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Injectable PrEP Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Injectable PrEP Consumption Value by Dosing Interval, (USD Million), 2021 & 2025 & 2032
Table 3. Global Injectable PrEP Consumption Value by Drug Properties, (USD Million), 2021 & 2025 & 2032
Table 4. Global Injectable PrEP Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 6. Gilead Sciences Major Business
Table 7. Gilead Sciences Injectable PrEP Product and Services
Table 8. Gilead Sciences Injectable PrEP Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Gilead Sciences Recent Developments/Updates
Table 10. ViiV Healthcare Basic Information, Manufacturing Base and Competitors
Table 11. ViiV Healthcare Major Business
Table 12. ViiV Healthcare Injectable PrEP Product and Services
Table 13. ViiV Healthcare Injectable PrEP Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. ViiV Healthcare Recent Developments/Updates
Table 15. Aurobindo Basic Information, Manufacturing Base and Competitors
Table 16. Aurobindo Major Business
Table 17. Aurobindo Injectable PrEP Product and Services
Table 18. Aurobindo Injectable PrEP Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Aurobindo Recent Developments/Updates
Table 20. Cipla Basic Information, Manufacturing Base and Competitors
Table 21. Cipla Major Business
Table 22. Cipla Injectable PrEP Product and Services
Table 23. Cipla Injectable PrEP Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Cipla Recent Developments/Updates
Table 25. Viatris Basic Information, Manufacturing Base and Competitors
Table 26. Viatris Major Business
Table 27. Viatris Injectable PrEP Product and Services
Table 28. Viatris Injectable PrEP Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Viatris Recent Developments/Updates
Table 30. Global Injectable PrEP Sales Quantity by Manufacturer (2021-2026) & (K Dose)
Table 31. Global Injectable PrEP Revenue by Manufacturer (2021-2026) & (USD Million)
Table 32. Global Injectable PrEP Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 33. Market Position of Manufacturers in Injectable PrEP, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 34. Head Office and Injectable PrEP Production Site of Key Manufacturer
Table 35. Injectable PrEP Market: Company Product Type Footprint
Table 36. Injectable PrEP Market: Company Product Application Footprint
Table 37. Injectable PrEP New Market Entrants and Barriers to Market Entry
Table 38. Injectable PrEP Mergers, Acquisition, Agreements, and Collaborations
Table 39. Global Injectable PrEP Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 40. Global Injectable PrEP Sales Quantity by Region (2021-2026) & (K Dose)
Table 41. Global Injectable PrEP Sales Quantity by Region (2027-2032) & (K Dose)
Table 42. Global Injectable PrEP Consumption Value by Region (2021-2026) & (USD Million)
Table 43. Global Injectable PrEP Consumption Value by Region (2027-2032) & (USD Million)
Table 44. Global Injectable PrEP Average Price by Region (2021-2026) & (US$/Dose)
Table 45. Global Injectable PrEP Average Price by Region (2027-2032) & (US$/Dose)
Table 46. Global Injectable PrEP Sales Quantity by Type (2021-2026) & (K Dose)
Table 47. Global Injectable PrEP Sales Quantity by Type (2027-2032) & (K Dose)
Table 48. Global Injectable PrEP Consumption Value by Type (2021-2026) & (USD Million)
Table 49. Global Injectable PrEP Consumption Value by Type (2027-2032) & (USD Million)
Table 50. Global Injectable PrEP Average Price by Type (2021-2026) & (US$/Dose)
Table 51. Global Injectable PrEP Average Price by Type (2027-2032) & (US$/Dose)
Table 52. Global Injectable PrEP Sales Quantity by Application (2021-2026) & (K Dose)
Table 53. Global Injectable PrEP Sales Quantity by Application (2027-2032) & (K Dose)
Table 54. Global Injectable PrEP Consumption Value by Application (2021-2026) & (USD Million)
Table 55. Global Injectable PrEP Consumption Value by Application (2027-2032) & (USD Million)
Table 56. Global Injectable PrEP Average Price by Application (2021-2026) & (US$/Dose)
Table 57. Global Injectable PrEP Average Price by Application (2027-2032) & (US$/Dose)
Table 58. North America Injectable PrEP Sales Quantity by Type (2021-2026) & (K Dose)
Table 59. North America Injectable PrEP Sales Quantity by Type (2027-2032) & (K Dose)
Table 60. North America Injectable PrEP Sales Quantity by Application (2021-2026) & (K Dose)
Table 61. North America Injectable PrEP Sales Quantity by Application (2027-2032) & (K Dose)
Table 62. North America Injectable PrEP Sales Quantity by Country (2021-2026) & (K Dose)
Table 63. North America Injectable PrEP Sales Quantity by Country (2027-2032) & (K Dose)
Table 64. North America Injectable PrEP Consumption Value by Country (2021-2026) & (USD Million)
Table 65. North America Injectable PrEP Consumption Value by Country (2027-2032) & (USD Million)
Table 66. Europe Injectable PrEP Sales Quantity by Type (2021-2026) & (K Dose)
Table 67. Europe Injectable PrEP Sales Quantity by Type (2027-2032) & (K Dose)
Table 68. Europe Injectable PrEP Sales Quantity by Application (2021-2026) & (K Dose)
Table 69. Europe Injectable PrEP Sales Quantity by Application (2027-2032) & (K Dose)
Table 70. Europe Injectable PrEP Sales Quantity by Country (2021-2026) & (K Dose)
Table 71. Europe Injectable PrEP Sales Quantity by Country (2027-2032) & (K Dose)
Table 72. Europe Injectable PrEP Consumption Value by Country (2021-2026) & (USD Million)
Table 73. Europe Injectable PrEP Consumption Value by Country (2027-2032) & (USD Million)
Table 74. Asia-Pacific Injectable PrEP Sales Quantity by Type (2021-2026) & (K Dose)
Table 75. Asia-Pacific Injectable PrEP Sales Quantity by Type (2027-2032) & (K Dose)
Table 76. Asia-Pacific Injectable PrEP Sales Quantity by Application (2021-2026) & (K Dose)
Table 77. Asia-Pacific Injectable PrEP Sales Quantity by Application (2027-2032) & (K Dose)
Table 78. Asia-Pacific Injectable PrEP Sales Quantity by Region (2021-2026) & (K Dose)
Table 79. Asia-Pacific Injectable PrEP Sales Quantity by Region (2027-2032) & (K Dose)
Table 80. Asia-Pacific Injectable PrEP Consumption Value by Region (2021-2026) & (USD Million)
Table 81. Asia-Pacific Injectable PrEP Consumption Value by Region (2027-2032) & (USD Million)
Table 82. South America Injectable PrEP Sales Quantity by Type (2021-2026) & (K Dose)
Table 83. South America Injectable PrEP Sales Quantity by Type (2027-2032) & (K Dose)
Table 84. South America Injectable PrEP Sales Quantity by Application (2021-2026) & (K Dose)
Table 85. South America Injectable PrEP Sales Quantity by Application (2027-2032) & (K Dose)
Table 86. South America Injectable PrEP Sales Quantity by Country (2021-2026) & (K Dose)
Table 87. South America Injectable PrEP Sales Quantity by Country (2027-2032) & (K Dose)
Table 88. South America Injectable PrEP Consumption Value by Country (2021-2026) & (USD Million)
Table 89. South America Injectable PrEP Consumption Value by Country (2027-2032) & (USD Million)
Table 90. Middle East & Africa Injectable PrEP Sales Quantity by Type (2021-2026) & (K Dose)
Table 91. Middle East & Africa Injectable PrEP Sales Quantity by Type (2027-2032) & (K Dose)
Table 92. Middle East & Africa Injectable PrEP Sales Quantity by Application (2021-2026) & (K Dose)
Table 93. Middle East & Africa Injectable PrEP Sales Quantity by Application (2027-2032) & (K Dose)
Table 94. Middle East & Africa Injectable PrEP Sales Quantity by Country (2021-2026) & (K Dose)
Table 95. Middle East & Africa Injectable PrEP Sales Quantity by Country (2027-2032) & (K Dose)
Table 96. Middle East & Africa Injectable PrEP Consumption Value by Country (2021-2026) & (USD Million)
Table 97. Middle East & Africa Injectable PrEP Consumption Value by Country (2027-2032) & (USD Million)
Table 98. Injectable PrEP Raw Material
Table 99. Key Manufacturers of Injectable PrEP Raw Materials
Table 100. Injectable PrEP Typical Distributors
Table 101. Injectable PrEP Typical Customers
Table 1. Global Injectable PrEP Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Injectable PrEP Consumption Value by Dosing Interval, (USD Million), 2021 & 2025 & 2032
Table 3. Global Injectable PrEP Consumption Value by Drug Properties, (USD Million), 2021 & 2025 & 2032
Table 4. Global Injectable PrEP Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 6. Gilead Sciences Major Business
Table 7. Gilead Sciences Injectable PrEP Product and Services
Table 8. Gilead Sciences Injectable PrEP Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Gilead Sciences Recent Developments/Updates
Table 10. ViiV Healthcare Basic Information, Manufacturing Base and Competitors
Table 11. ViiV Healthcare Major Business
Table 12. ViiV Healthcare Injectable PrEP Product and Services
Table 13. ViiV Healthcare Injectable PrEP Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. ViiV Healthcare Recent Developments/Updates
Table 15. Aurobindo Basic Information, Manufacturing Base and Competitors
Table 16. Aurobindo Major Business
Table 17. Aurobindo Injectable PrEP Product and Services
Table 18. Aurobindo Injectable PrEP Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Aurobindo Recent Developments/Updates
Table 20. Cipla Basic Information, Manufacturing Base and Competitors
Table 21. Cipla Major Business
Table 22. Cipla Injectable PrEP Product and Services
Table 23. Cipla Injectable PrEP Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Cipla Recent Developments/Updates
Table 25. Viatris Basic Information, Manufacturing Base and Competitors
Table 26. Viatris Major Business
Table 27. Viatris Injectable PrEP Product and Services
Table 28. Viatris Injectable PrEP Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Viatris Recent Developments/Updates
Table 30. Global Injectable PrEP Sales Quantity by Manufacturer (2021-2026) & (K Dose)
Table 31. Global Injectable PrEP Revenue by Manufacturer (2021-2026) & (USD Million)
Table 32. Global Injectable PrEP Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 33. Market Position of Manufacturers in Injectable PrEP, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 34. Head Office and Injectable PrEP Production Site of Key Manufacturer
Table 35. Injectable PrEP Market: Company Product Type Footprint
Table 36. Injectable PrEP Market: Company Product Application Footprint
Table 37. Injectable PrEP New Market Entrants and Barriers to Market Entry
Table 38. Injectable PrEP Mergers, Acquisition, Agreements, and Collaborations
Table 39. Global Injectable PrEP Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 40. Global Injectable PrEP Sales Quantity by Region (2021-2026) & (K Dose)
Table 41. Global Injectable PrEP Sales Quantity by Region (2027-2032) & (K Dose)
Table 42. Global Injectable PrEP Consumption Value by Region (2021-2026) & (USD Million)
Table 43. Global Injectable PrEP Consumption Value by Region (2027-2032) & (USD Million)
Table 44. Global Injectable PrEP Average Price by Region (2021-2026) & (US$/Dose)
Table 45. Global Injectable PrEP Average Price by Region (2027-2032) & (US$/Dose)
Table 46. Global Injectable PrEP Sales Quantity by Type (2021-2026) & (K Dose)
Table 47. Global Injectable PrEP Sales Quantity by Type (2027-2032) & (K Dose)
Table 48. Global Injectable PrEP Consumption Value by Type (2021-2026) & (USD Million)
Table 49. Global Injectable PrEP Consumption Value by Type (2027-2032) & (USD Million)
Table 50. Global Injectable PrEP Average Price by Type (2021-2026) & (US$/Dose)
Table 51. Global Injectable PrEP Average Price by Type (2027-2032) & (US$/Dose)
Table 52. Global Injectable PrEP Sales Quantity by Application (2021-2026) & (K Dose)
Table 53. Global Injectable PrEP Sales Quantity by Application (2027-2032) & (K Dose)
Table 54. Global Injectable PrEP Consumption Value by Application (2021-2026) & (USD Million)
Table 55. Global Injectable PrEP Consumption Value by Application (2027-2032) & (USD Million)
Table 56. Global Injectable PrEP Average Price by Application (2021-2026) & (US$/Dose)
Table 57. Global Injectable PrEP Average Price by Application (2027-2032) & (US$/Dose)
Table 58. North America Injectable PrEP Sales Quantity by Type (2021-2026) & (K Dose)
Table 59. North America Injectable PrEP Sales Quantity by Type (2027-2032) & (K Dose)
Table 60. North America Injectable PrEP Sales Quantity by Application (2021-2026) & (K Dose)
Table 61. North America Injectable PrEP Sales Quantity by Application (2027-2032) & (K Dose)
Table 62. North America Injectable PrEP Sales Quantity by Country (2021-2026) & (K Dose)
Table 63. North America Injectable PrEP Sales Quantity by Country (2027-2032) & (K Dose)
Table 64. North America Injectable PrEP Consumption Value by Country (2021-2026) & (USD Million)
Table 65. North America Injectable PrEP Consumption Value by Country (2027-2032) & (USD Million)
Table 66. Europe Injectable PrEP Sales Quantity by Type (2021-2026) & (K Dose)
Table 67. Europe Injectable PrEP Sales Quantity by Type (2027-2032) & (K Dose)
Table 68. Europe Injectable PrEP Sales Quantity by Application (2021-2026) & (K Dose)
Table 69. Europe Injectable PrEP Sales Quantity by Application (2027-2032) & (K Dose)
Table 70. Europe Injectable PrEP Sales Quantity by Country (2021-2026) & (K Dose)
Table 71. Europe Injectable PrEP Sales Quantity by Country (2027-2032) & (K Dose)
Table 72. Europe Injectable PrEP Consumption Value by Country (2021-2026) & (USD Million)
Table 73. Europe Injectable PrEP Consumption Value by Country (2027-2032) & (USD Million)
Table 74. Asia-Pacific Injectable PrEP Sales Quantity by Type (2021-2026) & (K Dose)
Table 75. Asia-Pacific Injectable PrEP Sales Quantity by Type (2027-2032) & (K Dose)
Table 76. Asia-Pacific Injectable PrEP Sales Quantity by Application (2021-2026) & (K Dose)
Table 77. Asia-Pacific Injectable PrEP Sales Quantity by Application (2027-2032) & (K Dose)
Table 78. Asia-Pacific Injectable PrEP Sales Quantity by Region (2021-2026) & (K Dose)
Table 79. Asia-Pacific Injectable PrEP Sales Quantity by Region (2027-2032) & (K Dose)
Table 80. Asia-Pacific Injectable PrEP Consumption Value by Region (2021-2026) & (USD Million)
Table 81. Asia-Pacific Injectable PrEP Consumption Value by Region (2027-2032) & (USD Million)
Table 82. South America Injectable PrEP Sales Quantity by Type (2021-2026) & (K Dose)
Table 83. South America Injectable PrEP Sales Quantity by Type (2027-2032) & (K Dose)
Table 84. South America Injectable PrEP Sales Quantity by Application (2021-2026) & (K Dose)
Table 85. South America Injectable PrEP Sales Quantity by Application (2027-2032) & (K Dose)
Table 86. South America Injectable PrEP Sales Quantity by Country (2021-2026) & (K Dose)
Table 87. South America Injectable PrEP Sales Quantity by Country (2027-2032) & (K Dose)
Table 88. South America Injectable PrEP Consumption Value by Country (2021-2026) & (USD Million)
Table 89. South America Injectable PrEP Consumption Value by Country (2027-2032) & (USD Million)
Table 90. Middle East & Africa Injectable PrEP Sales Quantity by Type (2021-2026) & (K Dose)
Table 91. Middle East & Africa Injectable PrEP Sales Quantity by Type (2027-2032) & (K Dose)
Table 92. Middle East & Africa Injectable PrEP Sales Quantity by Application (2021-2026) & (K Dose)
Table 93. Middle East & Africa Injectable PrEP Sales Quantity by Application (2027-2032) & (K Dose)
Table 94. Middle East & Africa Injectable PrEP Sales Quantity by Country (2021-2026) & (K Dose)
Table 95. Middle East & Africa Injectable PrEP Sales Quantity by Country (2027-2032) & (K Dose)
Table 96. Middle East & Africa Injectable PrEP Consumption Value by Country (2021-2026) & (USD Million)
Table 97. Middle East & Africa Injectable PrEP Consumption Value by Country (2027-2032) & (USD Million)
Table 98. Injectable PrEP Raw Material
Table 99. Key Manufacturers of Injectable PrEP Raw Materials
Table 100. Injectable PrEP Typical Distributors
Table 101. Injectable PrEP Typical Customers
LIST OF FIGURES
Figure 1. Injectable PrEP Picture
Figure 2. Global Injectable PrEP Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Injectable PrEP Revenue Market Share by Type in 2025
Figure 4. Cabotegravir Examples
Figure 5. Lenacapavir Examples
Figure 6. Other Examples
Figure 7. Global Injectable PrEP Revenue by Dosing Interval, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Injectable PrEP Revenue Market Share by Dosing Interval in 2025
Figure 9. Short-interval Injections Examples
Figure 10. Monthly Injections Examples
Figure 11. Quarterly Injections Examples
Figure 12. Global Injectable PrEP Revenue by Drug Properties, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Injectable PrEP Revenue Market Share by Drug Properties in 2025
Figure 14. Original Drug Examples
Figure 15. Generic Drug Examples
Figure 16. Global Injectable PrEP Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 17. Global Injectable PrEP Revenue Market Share by Application in 2025
Figure 18. Hospital Examples
Figure 19. Clinic Examples
Figure 20. Other Examples
Figure 21. Global Injectable PrEP Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 22. Global Injectable PrEP Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 23. Global Injectable PrEP Sales Quantity (2021-2032) & (K Dose)
Figure 24. Global Injectable PrEP Price (2021-2032) & (US$/Dose)
Figure 25. Global Injectable PrEP Sales Quantity Market Share by Manufacturer in 2025
Figure 26. Global Injectable PrEP Revenue Market Share by Manufacturer in 2025
Figure 27. Producer Shipments of Injectable PrEP by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 28. Top 3 Injectable PrEP Manufacturer (Revenue) Market Share in 2025
Figure 29. Top 6 Injectable PrEP Manufacturer (Revenue) Market Share in 2025
Figure 30. Global Injectable PrEP Sales Quantity Market Share by Region (2021-2032)
Figure 31. Global Injectable PrEP Consumption Value Market Share by Region (2021-2032)
Figure 32. North America Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 33. Europe Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 34. Asia-Pacific Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 35. South America Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 36. Middle East & Africa Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 37. Global Injectable PrEP Sales Quantity Market Share by Type (2021-2032)
Figure 38. Global Injectable PrEP Consumption Value Market Share by Type (2021-2032)
Figure 39. Global Injectable PrEP Average Price by Type (2021-2032) & (US$/Dose)
Figure 40. Global Injectable PrEP Sales Quantity Market Share by Application (2021-2032)
Figure 41. Global Injectable PrEP Revenue Market Share by Application (2021-2032)
Figure 42. Global Injectable PrEP Average Price by Application (2021-2032) & (US$/Dose)
Figure 43. North America Injectable PrEP Sales Quantity Market Share by Type (2021-2032)
Figure 44. North America Injectable PrEP Sales Quantity Market Share by Application (2021-2032)
Figure 45. North America Injectable PrEP Sales Quantity Market Share by Country (2021-2032)
Figure 46. North America Injectable PrEP Consumption Value Market Share by Country (2021-2032)
Figure 47. United States Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 48. Canada Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 49. Mexico Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 50. Europe Injectable PrEP Sales Quantity Market Share by Type (2021-2032)
Figure 51. Europe Injectable PrEP Sales Quantity Market Share by Application (2021-2032)
Figure 52. Europe Injectable PrEP Sales Quantity Market Share by Country (2021-2032)
Figure 53. Europe Injectable PrEP Consumption Value Market Share by Country (2021-2032)
Figure 54. Germany Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 55. France Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 56. United Kingdom Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 57. Russia Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 58. Italy Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 59. Asia-Pacific Injectable PrEP Sales Quantity Market Share by Type (2021-2032)
Figure 60. Asia-Pacific Injectable PrEP Sales Quantity Market Share by Application (2021-2032)
Figure 61. Asia-Pacific Injectable PrEP Sales Quantity Market Share by Region (2021-2032)
Figure 62. Asia-Pacific Injectable PrEP Consumption Value Market Share by Region (2021-2032)
Figure 63. China Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 64. Japan Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 65. South Korea Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 66. India Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 67. Southeast Asia Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 68. Australia Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 69. South America Injectable PrEP Sales Quantity Market Share by Type (2021-2032)
Figure 70. South America Injectable PrEP Sales Quantity Market Share by Application (2021-2032)
Figure 71. South America Injectable PrEP Sales Quantity Market Share by Country (2021-2032)
Figure 72. South America Injectable PrEP Consumption Value Market Share by Country (2021-2032)
Figure 73. Brazil Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 74. Argentina Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 75. Middle East & Africa Injectable PrEP Sales Quantity Market Share by Type (2021-2032)
Figure 76. Middle East & Africa Injectable PrEP Sales Quantity Market Share by Application (2021-2032)
Figure 77. Middle East & Africa Injectable PrEP Sales Quantity Market Share by Country (2021-2032)
Figure 78. Middle East & Africa Injectable PrEP Consumption Value Market Share by Country (2021-2032)
Figure 79. Turkey Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 80. Egypt Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 81. Saudi Arabia Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 82. South Africa Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 83. Injectable PrEP Market Drivers
Figure 84. Injectable PrEP Market Restraints
Figure 85. Injectable PrEP Market Trends
Figure 86. Porters Five Forces Analysis
Figure 87. Manufacturing Cost Structure Analysis of Injectable PrEP in 2025
Figure 88. Manufacturing Process Analysis of Injectable PrEP
Figure 89. Injectable PrEP Industrial Chain
Figure 90. Sales Channel: Direct to End-User vs Distributors
Figure 91. Direct Channel Pros & Cons
Figure 92. Indirect Channel Pros & Cons
Figure 93. Methodology
Figure 94. Research Process and Data Source
Figure 1. Injectable PrEP Picture
Figure 2. Global Injectable PrEP Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Injectable PrEP Revenue Market Share by Type in 2025
Figure 4. Cabotegravir Examples
Figure 5. Lenacapavir Examples
Figure 6. Other Examples
Figure 7. Global Injectable PrEP Revenue by Dosing Interval, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Injectable PrEP Revenue Market Share by Dosing Interval in 2025
Figure 9. Short-interval Injections Examples
Figure 10. Monthly Injections Examples
Figure 11. Quarterly Injections Examples
Figure 12. Global Injectable PrEP Revenue by Drug Properties, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Injectable PrEP Revenue Market Share by Drug Properties in 2025
Figure 14. Original Drug Examples
Figure 15. Generic Drug Examples
Figure 16. Global Injectable PrEP Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 17. Global Injectable PrEP Revenue Market Share by Application in 2025
Figure 18. Hospital Examples
Figure 19. Clinic Examples
Figure 20. Other Examples
Figure 21. Global Injectable PrEP Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 22. Global Injectable PrEP Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 23. Global Injectable PrEP Sales Quantity (2021-2032) & (K Dose)
Figure 24. Global Injectable PrEP Price (2021-2032) & (US$/Dose)
Figure 25. Global Injectable PrEP Sales Quantity Market Share by Manufacturer in 2025
Figure 26. Global Injectable PrEP Revenue Market Share by Manufacturer in 2025
Figure 27. Producer Shipments of Injectable PrEP by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 28. Top 3 Injectable PrEP Manufacturer (Revenue) Market Share in 2025
Figure 29. Top 6 Injectable PrEP Manufacturer (Revenue) Market Share in 2025
Figure 30. Global Injectable PrEP Sales Quantity Market Share by Region (2021-2032)
Figure 31. Global Injectable PrEP Consumption Value Market Share by Region (2021-2032)
Figure 32. North America Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 33. Europe Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 34. Asia-Pacific Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 35. South America Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 36. Middle East & Africa Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 37. Global Injectable PrEP Sales Quantity Market Share by Type (2021-2032)
Figure 38. Global Injectable PrEP Consumption Value Market Share by Type (2021-2032)
Figure 39. Global Injectable PrEP Average Price by Type (2021-2032) & (US$/Dose)
Figure 40. Global Injectable PrEP Sales Quantity Market Share by Application (2021-2032)
Figure 41. Global Injectable PrEP Revenue Market Share by Application (2021-2032)
Figure 42. Global Injectable PrEP Average Price by Application (2021-2032) & (US$/Dose)
Figure 43. North America Injectable PrEP Sales Quantity Market Share by Type (2021-2032)
Figure 44. North America Injectable PrEP Sales Quantity Market Share by Application (2021-2032)
Figure 45. North America Injectable PrEP Sales Quantity Market Share by Country (2021-2032)
Figure 46. North America Injectable PrEP Consumption Value Market Share by Country (2021-2032)
Figure 47. United States Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 48. Canada Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 49. Mexico Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 50. Europe Injectable PrEP Sales Quantity Market Share by Type (2021-2032)
Figure 51. Europe Injectable PrEP Sales Quantity Market Share by Application (2021-2032)
Figure 52. Europe Injectable PrEP Sales Quantity Market Share by Country (2021-2032)
Figure 53. Europe Injectable PrEP Consumption Value Market Share by Country (2021-2032)
Figure 54. Germany Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 55. France Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 56. United Kingdom Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 57. Russia Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 58. Italy Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 59. Asia-Pacific Injectable PrEP Sales Quantity Market Share by Type (2021-2032)
Figure 60. Asia-Pacific Injectable PrEP Sales Quantity Market Share by Application (2021-2032)
Figure 61. Asia-Pacific Injectable PrEP Sales Quantity Market Share by Region (2021-2032)
Figure 62. Asia-Pacific Injectable PrEP Consumption Value Market Share by Region (2021-2032)
Figure 63. China Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 64. Japan Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 65. South Korea Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 66. India Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 67. Southeast Asia Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 68. Australia Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 69. South America Injectable PrEP Sales Quantity Market Share by Type (2021-2032)
Figure 70. South America Injectable PrEP Sales Quantity Market Share by Application (2021-2032)
Figure 71. South America Injectable PrEP Sales Quantity Market Share by Country (2021-2032)
Figure 72. South America Injectable PrEP Consumption Value Market Share by Country (2021-2032)
Figure 73. Brazil Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 74. Argentina Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 75. Middle East & Africa Injectable PrEP Sales Quantity Market Share by Type (2021-2032)
Figure 76. Middle East & Africa Injectable PrEP Sales Quantity Market Share by Application (2021-2032)
Figure 77. Middle East & Africa Injectable PrEP Sales Quantity Market Share by Country (2021-2032)
Figure 78. Middle East & Africa Injectable PrEP Consumption Value Market Share by Country (2021-2032)
Figure 79. Turkey Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 80. Egypt Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 81. Saudi Arabia Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 82. South Africa Injectable PrEP Consumption Value (2021-2032) & (USD Million)
Figure 83. Injectable PrEP Market Drivers
Figure 84. Injectable PrEP Market Restraints
Figure 85. Injectable PrEP Market Trends
Figure 86. Porters Five Forces Analysis
Figure 87. Manufacturing Cost Structure Analysis of Injectable PrEP in 2025
Figure 88. Manufacturing Process Analysis of Injectable PrEP
Figure 89. Injectable PrEP Industrial Chain
Figure 90. Sales Channel: Direct to End-User vs Distributors
Figure 91. Direct Channel Pros & Cons
Figure 92. Indirect Channel Pros & Cons
Figure 93. Methodology
Figure 94. Research Process and Data Source
